David Hallett
Chief Scientific Officer · RECURSION PHARMACEUTICALS, INC.
Individual
- 2026
- Aug 18, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Hallett files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Blake Borgeson - $3.38M in RXRX purchases and sales in the last 12 months
- Christopher Gibson - $2.41M in RXRX purchases and sales in the last 12 months
- Najat Khan - $258K in RXRX purchases and sales in the last 12 months
- Robert Hershberg - $125K in RXRX purchases and sales in the last 12 months
- Ben R. Taylor - $68K in RXRX purchases and sales in the last 12 months
- Namandje Bumpus - $28K in RXRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Hallett?
David Hallett is a corporate insider, tracked as Chief Scientific Officer of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Hallett submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
